This could be very important info for men with PCa.
Followers of my posts will recall that control of abnormal coagulation is a key concern of mine, having experienced a double DVT in my left leg. Coagulation is altered in most cancers & increases the likelihood of blood clots & metastasis. In the U.S. doctors do not treat until there is a serious event. The D-dimer test is useful in determining whether or not there is a clot. If one presents at the ER with chest pain, a negative D-dimer result rules out a blood clot to the lungs.
The reason that D-dimer is not tested in cancer patients is that there is no low-risk prophylactic response. Warfarin, for instance, is only used when there is a life-threatening clot. An elevated D-dimer is not sufficient evidence & might be elevated for another reason.
I test D-dimer a few times a year. I use it to monitor that I am using an appropriate amount of nattokinase daily. Nattokinase dissolves fibrin. The body disolves fibrin slowly with plasmin. Nattokinase is similar to plasmin but the boost it provides can help one keep ahead of cancer clot formation.
***
"TAKE-HOME MESSAGE
"The authors of this retrospective analysis evaluated coagulation parameters in 183 patients admitted with the severe novel coronavirus COVID-19. Median age at admission was 54 years, and 71.4% of non-survivors developed overt disseminated intravascular coagulation (DIC), with a median time from admission to DIC of 4 days. Only 0.6% of survivors developed DIC. On admission, non-surviving patients presented with higher D-dimer levels, prolonged PT, and aPTT compared with surviving patients.
"In patients with COVID-19 infection, the development of coagulopathy and overt DIC appears to be associated with a high mortality rate. Larger analyses confirming these findings and investigating both the pathophysiology and impact of correction of coagulopathy on mortality are warranted.
– Curtis Lachowiez, MD" [1]
***
"Conventional coagulation results and outcomes of consecutive 183 patients with confirmed NCP in Tongji hospital were retrospectively analysed." [2]
"71.4% of non‐survivors and 0.6% survivors met the criteria of disseminated intravascular coagulation during their hospital stay."
"The present study shows that abnormal coagulation results, especially markedly elevated D‐dimer and FDP are common in deaths with NCP."
-Patrick
[1] practiceupdate.com/c/97218/...